Newsroom | 12014 results

LONDON--(BUSINESS WIRE)--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science...

CAMP HILL, Pa.--(BUSINESS WIRE)--Forma Medical Inc. announced a sharpened strategic focus on OptimalMTP™, a procedural innovation enabling minimally invasive plating of first metatarsophalangeal (MTP) joint fusion, along with the issuance of a key methods patent and the appointment of Aaron Smith, former CEO of Artelon, to its Board of Directors. The commercial growth of OptimalMTP™ has accelerated since its launch, with demonstrated clinical success in over 650 patients. Building on this clini...

CLINTON, Mo.--(BUSINESS WIRE)--Golden Valley Memorial Healthcare Expands Surgical Care With da Vinci® 5 (DV5) Robotic System...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency. Domestic revenue increased 1.4% year-over-year. International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to dilute...

NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, is announcing a partnership with Ema, the leader in agentic AI, to deploy intelligent AI agents that transforms how patients access care. The partnership, which launches with patient scheduling and triage, is designed to reduce wait times, improve appointment accuracy, and ensure patients connect with the right specialist faster, accelerating their path t...

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE® to reintegrate cranial bone flaps, which are portions of the skull that are temporarily removed by neurosurgeons to perform brain surgery. This clinical trial is designed to demonstrate that TETRANITE can immediately fixate cranial flaps and enable bone fusion in cranioto...

MARQUETTE, Mich.--(BUSINESS WIRE)--Able Medical announced the completion of the 10,000th procedure in the U.S. with the Valkyrie Thoracic Fixation System....

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether Natera’s Prospera Heart test can replace routine invasive biopsies for rejection monitoring in heart transplant recipients. Positive results would support a fundamental shift in the standard of care for heart transplant recipients away from invasive tissue sampling...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Haaglanden Medical Center (HMC) will become the first hospital in the Netherlands to install the vault-free, cobalt-free ZAP-X® Gyroscopic Radiosurgery® platform. The system will be installed within the radiotherapy department at HMC, further strengthening the hospital’s role as a national and regional referral center for complex neuro-oncology and neurova...

GLASGOW, Scotland--(BUSINESS WIRE)--Ultrasonic surgery specialist Nami Surgical has appointed Nikki Palfrey as CEO while completing its latest investment round. The company is targeting the global robotic-assisted surgery market with its pioneering ultrasonic technology, with the funding supporting the company’s transition from advanced development to commercialisation. Nami develops high-performance miniaturised ultrasonic scalpels; its platform has been engineered for integration into articul...